Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cancer Research

• Publication date

  2016-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-15-2910PMID 27457520
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic pathways promoting cancer cell survival and growth

  2015cited by this paper
• Bioenergetic differences between MCF-7 and T47D breast cancer cells and their regulation by oestradiol and tamoxifen.

  2015cited by this paper
• A joint analysis of metabolomics and genetics of breast cancer

  2014cited by this paper
• Glutamine and cancer: cell biology, physiology, and clinical opportunities.

  2013cited by this paper
• Metabolic targets for cancer therapy

  2013cited by this paper
• Tumor glycolysis as a target for cancer therapy: progress and prospects

  2013cited by this paper
• Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: alterations in glutamine and beta-alanine metabolism.

  2013cited by this paper
• Absolute Quantification of Choline-Related Biomarkers in Breast Cancer Biopsies by Liquid Chromatography Electrospray Ionization Mass Spectrometry

  2013cited by this paper
• Glycerophosphocholine (GPC) is a poorly understood biomarker in breast cancer

  2012cited by this paper
• Estrogen modulates metabolic pathway adaptation to available glucose in breast cancer cells.

  2012cited by this paper
• Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis

  2012cited by this paper
• Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.

  2012cited by this paper
• Regulation of cancer cell metabolism

  2011cited by this paper
• Differential oestrogen receptor binding is associated with clinical outcome in breast cancer

  2011cited by this paper
• MR‐visible lipids and the tumor microenvironment

  2011cited by this paper
• Choline metabolism in malignant transformation

  2011influential reference
• The different roles of ER subtypes in cancer biology and therapy

  2011cited by this paper
• Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs.

  2010cited by this paper
• Integrative model of genomic factors for determining binding site selection by estrogen receptor-α

  2010cited by this paper
• The Kennedy pathway—De novo synthesis of phosphatidylethanolamine and phosphatidylcholine

  2010cited by this paper
• Supplementary information for Integrative model of genomic factors for determining binding site selection by estrogen receptor α

  2010cited by this paper
• Hypoxia-induced metastasis model in embryonic zebrafish

  2010cited by this paper
• Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics.

  2010cited by this paper
• Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models

  2010cited by this paper
• Fatty acid synthase as a potential therapeutic target in cancer.

  2010cited by this paper
• Genomic antagonism between retinoic acid and estrogen signaling in breast cancer.

  2009cited by this paper
• Regulation of ERBB2 by oestrogen receptor–PAX2 determines response to tamoxifen

  2008cited by this paper
• Gene expression profiles in breast cancer to identify estrogen receptor target genes.

  2008cited by this paper
• Choline metabolism and risk of breast cancer in a population‐based study

  2008cited by this paper
• Estrogen receptor β2 negatively regulates the transactivation of estrogen receptor α in human breast cancer cells

  2007cited by this paper
• Phosphatidylethanolamine N‐methyltransferase (PEMT) gene expression is induced by estrogen in human and mouse primary hepatocytes

  2007cited by this paper
• Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.

  2007cited by this paper
• Expression of estrogen receptor α, retinoic acid receptor α and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells

  2005cited by this paper
• Modulation of cholinephosphotransferase activity in breast cancer cell lines by Ro5-4864, a peripheral benzodiazepine receptor agonist.

  2005cited by this paper
• Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells.

  2005cited by this paper
• Molecular Causes of the Aberrant Choline Phospholipid Metabolism in Breast Cancer

  2004cited by this paper
• Choline phospholipid metabolism: A target in cancer cells?

  2003cited by this paper
• Differential expression of cholinephosphotransferase in normal and cancerous human mammary epithelial cells.

  2002cited by this paper
• Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis.

  2002cited by this paper
• Differential routing of choline in implanted breast cancer and normal organs

  2001cited by this paper
• Regulation of cholinephosphotransferase by thyroid hormone.

  2001cited by this paper
• Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells.

  1999influential reference
• Nm23‐transfected MDA‐mB‐435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: A 31P nuclear magnetic resonance study in vivo and in vitro

  1999cited by this paper
• Phorbol ester stimulation of phosphatidylcholine synthesis requires expression of both protein kinase C-alpha and phospholipase D.

  1998cited by this paper
• Metabolic changes underlying 31P MR spectral alterations in human hepatic tumours

  1998cited by this paper
• The modulation of choline phosphoglyceride metabolism in human colon cancer

  1996cited by this paper
• Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells.

  1996cited by this paper
• Metastasis-associated alterations in phospholipids and fatty acids of human prostatic adenocarcinoma cell lines.

  1992cited by this paper
• Early estrogen-induced metabolic changes and their inhibition by actinomycin D and cycloheximide in human breast cancer cells: 31P and 13C NMR studies.

  1989cited by this paper
• Metabolic studies of estrogen- and tamoxifen-treated human breast cancer cells by nuclear magnetic resonance spectroscopy.

  1989cited by this paper
• Effects of 12-O-tetradecanoylphorbol 13-acetate on glycerolipid metabolism in cultured myoblasts.

  1982cited by this paper
• Rapid stimulation of phospholipid metabolism in bovine lymphocytes by tumor-promoting phorbol esters.

  1978cited by this paper
• The early stimulation of phospholipid metabolism by 12-0-tetradecanoyl-phorbol-13-acetate and its specificity for tumor promotion.

  1973cited by this paper
• Estrogen Receptor (cid:1) Controls a Gene Network in Luminal-Like Breast Cancer Cells Comprising Multiple Transcription Factors and MicroRNAs

  year unknowncited by this paper

• Phosphatidylcholine and CHPT1 as Central Drivers of Chemoresistance in Colorectal Cancer: Lipidomic and Functional Insights

  2026cites this paper
• The CHPT-pSTAT3-SLC7A11 signaling axis controls progression and ferroptosis susceptibility of pancreatic cancer

  2025cites this paper
• The vitamin D3 axis in laryngeal cancer: a double-edged sword modulated by estrogen signaling

  2025cites this paper
• Molecular Mediators of Metabolic Reprogramming in Cancer: Mechanisms, Regulatory Networks, and Therapeutic Strategies

  2025cites this paper
• The calcium homeostasis in tumor and the mechanism involving progression and metastasis.

  2025cites this paper
• SREBP1-Dependent Metabolism as a Potential Target for Breast Cancer Risk Reduction

  2025cites this paper
• Prognostic significance of total choline on in-vivo proton MR spectroscopy for prediction of late recurrence in patients with hormone receptor-positive, HER2-negative early breast cancer

  2025cites this paper
• ZNF32 histidine 179 and 183 single-site and double-site mutations promote nuclear speckle formation but differentially regulate the proliferation of breast cancer cells

  2025cites this paper
• ASCT2 is a major contributor to serine uptake in cancer cells

  2024cites this paper
• In Silico Design of Dual Estrogen Receptor and Hsp90 Inhibitors for ER-Positive Breast Cancer Through a Mixed Ligand/Structure-Based Approach

  2024cites this paper
• Clinical measures in chronic neuropathic pain are related to the Kennedy and endocannabinoid pathways

  2024cites this paper
• Mitochondrial-related genes as prognostic and metastatic markers in breast cancer: insights from comprehensive analysis and clinical models

  2024cites this paper
• Mechanistic analysis of enhancer sequences in the estrogen receptor transcriptional program

  2024cites this paper
• Spectrophotometric determination of L-α-glycerylphosphorylcholine in pharmaceutical formulations and industrial equipment cleaning rinse water with the WAKO Phospholipids C assay kit

  2023cites this paper
• Lipid profile in breast cancer: From signaling pathways to treatment strategies.

  2023cites this paper
• ASCT2 is the primary serine transporter in cancer cells

  2023cites this paper
• The Metabolic Landscape of Breast Cancer and Its Therapeutic Implications

  2023cites this paper
• Metabolic Adaptations in an Endocrine-Related Breast Cancer Mouse Model Unveil Potential Markers of Tumor Response to Hormonal Therapy

  2022influential citation
• Sex hormones in breast cancer immunity.

  2022cites this paper
• Expression and activation of nuclear hormone receptors result in neuronal differentiation and favorable prognosis in neuroblastoma

  2022cites this paper
• The Metabolic Signature of AML Cells Treated With Homoharringtonine

  2022cites this paper
• Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer

  2022cites this paper
• Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers

  2021cites this paper
• CHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast cancer

  2021cites this paper
• A protein-fragment complementation assay reveals that celastrol and gambogic acid suppress ERα mutants in breast cancer.

  2021cites this paper
• The Heterogeneity of Breast Cancer Metabolism.

  2021cites this paper
• Targeting Metabolic Reprogramming to Improve Breast Cancer Treatment: An In Vitro Evaluation of Selected Metabolic Inhibitors Using a Metabolomic Approach

  2021cites this paper
• Argininosuccinate lyase is a metabolic vulnerability in breast development and cancer

  2021cites this paper
• Lipid metabolism part II

  2021cites this paper
• An unusual nicotinamide derivative, 4-pyridone-3-carboxamide ribonucleoside (4PYR), is a novel endothelial toxin and oncometabolite

  2021cites this paper
• The E3 ligase COP1 promotes ERα signaling and suppresses EMT in breast cancer

  2021cites this paper
• The Identification of Blood Biomarkers of Chronic Neuropathic Pain by Comparative Transcriptomics

  2021cites this paper
• Tumor Biology and Multidisciplinary Strategies of Oligometastasis in Gastrointestinal Cancers.

  2020cites this paper
• The Potential of Metabolomics in the Diagnosis of Thyroid Cancer

  2020cites this paper
• Mechanistic analysis of enhancer sequences in the Estrogen Receptor transcriptional program

  2020cites this paper
• AGR3 promotes estrogen receptor-positive breast cancer cell proliferation in an estrogen-dependent manner

  2020cites this paper
• Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy

  2020cites this paper
• ERα-related chromothripsis enhances concordant gene transcription on chromosome 17q11.1-q24.1 in luminal breast cancer

  2020cites this paper
• Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer

  2020cites this paper
• A model of twenty-three metabolic-related genes predicting overall survival for lung adenocarcinoma

  2020cites this paper
• Crosstalk between Estrogen Signaling and Breast Cancer Metabolism.

  2019cites this paper
• A multi-omics approach to uncover estrogen receptor (ER) and activator protein 1 (AP-1) signaling networks in breast cancer

  2019cites this paper
• Effects of carbon sources on 17 beta-estradiol degradation by Sphingomonas sp. and the analysis of the involved intracellular metabolomics.

  2019cites this paper
• Knockdown of ZBTB7A inhibits cell proliferation of breast cancer through regulating the ubiquitination of estrogen receptor alpha.

  2019cites this paper
• Editor's Note: Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism.

  2019cites this paper
• Breast Cancer Metabolism.

  2018cites this paper
• Effects of α-zearalenol on the metabolome of two breast cancer cell lines by 1H-NMR approach

  2018cites this paper
• c-Jun/AP-1 overexpression reprograms ERα signaling related to tamoxifen response in ERα-positive breast cancer

  2018cites this paper
• Intracytoplasmic lipid droplets in high grade glioma : metabolism and target for therapy

  2018cites this paper
• Expression of hormone receptors in oropharyngeal squamous cell carcinoma

  2018cites this paper
• Personalized Medicine in Malignant Melanoma: Towards Patient Tailored Treatment

  2018cites this paper
• Do racial differences exist in the association between pregnancy-induced hypertension and breast cancer risk?

  2017cites this paper
• Deciphering metabolic rewiring in breast cancer subtypes

  2017cites this paper
• Metabolic characterization and pathway analysis of berberine protects against prostate cancer

  2017cites this paper
• Investigation of discriminant metabolites in tamoxifen-resistant and choline kinase-alpha-downregulated breast cancer cells using 1H-nuclear magnetic resonance spectroscopy

  2017cites this paper
• Screening the active compounds of Phellodendri Amurensis cortex for treating prostate cancer by high-throughput chinmedomics

  2017cites this paper
• ZEB1 induces ER-α promoter hypermethylation and confers antiestrogen resistance in breast cancer

  2017cites this paper